1. Introduction {#sec1}
===============

Bacteria of the *Enterobacter cloacae complex* (*ECC*), which comprises six species, namely, *E. cloacae*, *E. asburiae*, *E. hormaechei*, *E. kobei*, *E. ludwigii*, and *E. nimipressuralis* \[[@B1]\], are widely distributed in nature. As pathogens, *ECC* species are highly adapted to the environment and are able to contaminate hospital medical devices. Currently, *E. cloacae* and *E. hormaechei* are most frequently isolated from human clinical specimens, and *E. cloacae* is among the *Enterobacter* sp. that have most commonly caused nosocomial infections in the last decade \[[@B2]\]. Furthermore, *E. cloacae* has assumed clinical importance and has emerged as a major human pathogen; it accounts for up to 5% of hospital-acquired bacteremia cases, 5% of nosocomial pneumonia cases, 4% of nosocomial urinary tract infections, and 10% of postsurgical peritonitis cases \[[@B3]\].

Owing to the low-level but inducible expression of a chromosomal *ampC* gene encoding the AmpC *β*-lactamase, *E. cloacae* is intrinsically resistant to ampicillin, amoxicillin-clavulanate, and first-generation cephalosporins \[[@B4]\]. Generally, the resistance of *E. cloacae* to third-generation cephalosporins is caused by its overproduction of the AmpC *β*-lactamases when the production of this cephalosporinase is inducible in the presence of strong *β*-lactam antibiotics (cefoxitin and imipenem); thus, treatment with third-generation cephalosporins may promote the development of AmpC-overproducing mutants. AmpC-producing organisms become resistant to almost all *β*-lactam antibiotics, with the exception of cefepime, cefpirome, and carbapenems. Most chromosomal *ampC* genes are inducible in the presence of certain agents such as cefoxitin and imipenem. Inducible AmpC expression is regulated by AmpR in the presence of two other gene products, namely, AmpD and AmpG. The regulation of AmpC production has been historically understood to require three proteins: AmpG, a plasma membrane-bound permease; AmpD, a cytosolic peptidoglycan-recycling amidase; and AmpR, the transcriptional regulator of AmpC. Derepression has been associated previously with structural defects within the *ampD* gene or with decreased *ampD* expression. Derepression represents the inability of AmpR to keep AmpC expression at constitutively low wild-type levels \[[@B5]\]. As a result, the AmpC enzyme confers resistance to third-generation cephalosporins and is not inhibited by common *β*-lactamase inhibitors. However, fourth-generation cephalosporins still retain activity against most *Enterobacteriaceae* strains.

In addition to therapeutic antibiotic agents, a large number of other chemical substances with antibacterial activities, such as heavy metals and detergents, are used in human health care and agricultural practices. Recently, concerns have been raised regarding coselection for antibiotic resistance among bacteria exposed to disinfectants and heavy metals (particularly copper, zinc, and mercury) used in some livestock species as growth promoters and therapeutic agents \[[@B6]\]. *Enterobacteriaceae* (including *E. coli*, *K. pneumoniae*, and *E. cloacae*) are highly adept at acquiring resistance genes to all disinfectants, heavy metals, and antibiotics through horizontal gene transfer between different bacteria within the environment; such genes include extended-spectrum beta-lactamases (ESBLs), copper and arsenic resistance systems (the *pco and ars* operons), and enzymes that hydrolyze cephalosporins (AmpC enzymes) \[[@B7], [@B8]\]. Many gram-negative organisms (such as *E. coli*, *E. cloacae*, and *K. pneumoniae*) encode broad-substrate efflux pumps \[[@B6], [@B7], [@B9]\], and a variety of multidrug pumps that have activity against disinfectants are similarly encoded by some gram-positive organisms, including *Staphylococcus aureus* \[[@B9], [@B10]\]. Besides the efflux pumps, other mechanisms such as chemisorption facilitating cadmium to bind to the bacterial surface also played a role in the heavy metal (cadmium) resistance \[[@B11]\]. Alternatively, in both gram-positive and gram-negative bacteria, mechanisms of acquired resistance to disinfectants may be associated with efflux pump-encoding genes introduced on mobile genetic elements or, in gram-negative bacteria, with mutations causing the constitutive overexpression of efflux pumps. Compared with antibiotics and disinfectants, heavy metals (copper, arsenic, zinc, and mercury) are very persistent in the environment and may accumulate in soil, water, and sediments from agricultural practices as well as from other sources such as aquacultural and industrial effluents \[[@B12]\]. Like the mechanisms of resistance to disinfectants, efflux pumps can expel heavy metal ions; such pumps include elements of the *czc* system, which encodes a pump for zinc, cobalt, and cadmium, and *pcoA*, which is an element of a copper extrusion system (W. \[[@B13]\]).

In this study, we identified *β*-lactamase genes in 212 clinical *E. cloacae* isolates and sequenced a *bla* ~MIR~ gene-carrying strain. Molecular analyses were performed to analyze the function of the resistance genes, and a comparative genomics analysis was conducted to elucidate the potential horizontal gene transfer patterns of genes related to both antibiotic and heavy metal resistance between bacteria of different species or genera. Our analysis revealed the distinct structure of a large plasmid carrying multiple clusters of heavy metal resistance genes that, to our knowledge, have not been described previously in *E. cloacae*.

2. Materials and Methods {#sec2}
========================

2.1. Bacterial Strain Collection, Genomic DNA Extraction, and High-Throughput Sequencing {#sec2.1}
----------------------------------------------------------------------------------------

A total of 212 nonduplicate clinically significant *E. cloacae* strains were isolated from the First Affiliated Hospital of Wenzhou Medical University (Zhejiang, China) between 2008 and 2012. These isolates were identified by a VITEK 60 microbial autoanalyzer (bioMérieux, Lyon, France). Bacteria and plasmids used in this study are listed in [Table 1](#tab1){ref-type="table"}. Among the isolates, 31, 36, 43, 32, and 70 strains were isolated in the years 2008, 2009, 2010, 2011, and 2012, respectively. All strains were resistant to a minimum of one or two antibiotics. For pooled genomic DNA sequencing, each clinical strain was incubated in 5 mL of Luria-Bertani (LB) broth at 37°C for approximately 16 h to obtain a concentration equivalent to an optimum optical density (OD~600~ = 1.5 ± 0.2). The cultures were pooled, and genomic DNA was extracted from 100 mL of the mixed bacteria using an AxyPrep Bacterial Genomic DNA Miniprep Kit (Axygen Scientific, Union City, CA, USA). The pooled genomic DNA was sequenced with a HiSeq 2500 DNA sequencer at Annoroad Gene Technology Co. Ltd. (Beijing, China). Reads derived from the HiSeq 2500 sequencing were initially assembled de novo with SOAPdenovo software to obtain contigs of the genome sequences. Glimmer software (<http://ccb.jhu.edu/software/glimmer>) was used to predict protein-coding genes with potential open reading frames (ORF) \> 150 bp in length. BLASTX (<https://blast.ncbi.nlm.nih.gov>) was used to annotate the predicted protein-coding genes against the nonredundant protein database with an e-value threshold of 1*E*-5.

2.2. Collection of Reference Sequences for Resistance Genes and Mapping of Sequencing Reads to the Reference Genes {#sec2.2}
------------------------------------------------------------------------------------------------------------------

The nucleotide sequences of all *β*-lactamase genes, including those encoding for Ambler class A, B, C, and D *β*-lactamases, were obtained from the GenBank nucleotide database, and the high-throughput sequencing reads were mapped to the reference sequences of the *β*-lactamase genes as previously described \[[@B14]\]. The relative abundance (sequencing depth) of a certain gene was calculated as the cumulative nucleotide length of the mapped short reads on the gene divided by the gene size.

2.3. Screening of *β*-Lactamase Gene-Positive Strains and Cloning and Phylogenetic Analysis of *bla* ~MIR~ Genes {#sec2.3}
----------------------------------------------------------------------------------------------------------------

The *E. cloacae* strains were screened by PCR amplification for the presence of *β*-lactamase genes as previously described \[[@B15]--[@B18]\]. The primers used for the cloning of complete ORFs contained a pair of flanking restriction endonuclease adapters (*BamH*I for the forward primers and *Hind*III for the reverse primers) and were designed using the Primer Premier 5.0 software package; the primers are shown in [Table 2](#tab2){ref-type="table"}. Genomic DNA was extracted from each of the 212 clinical *E. cloacae* isolates using the AxyPrep Bacterial Genomic DNA Miniprep kit (Axygen Scientific, Union City, CA, USA) and was used as the template for PCR amplification. Positive amplification products were verified by sequencing with an ABI 3730 automated sequencer (Shanghai Sunny Biotechnology Co. Ltd., Shanghai, China), and the sequencing results were compared with Basic Local Alignment Search Tool (BLAST) algorithms (<https://blast.ncbi.nlm.nih.gov/blast.cgi>). The amplicons of the *bla* ORFs were digested with the corresponding restriction endonucleases and ligated into the pET-28a vector with a T4 DNA ligase cloning kit (Takara Bio Inc., Dalian, China). The recombinant plasmid was transformed into competent *E. coli* BL21 cells using the calcium chloride method and cultured on LB agar plates supplemented with ampicillin (200 *μ*g/mL), and the cloned ORFs were confirmed by sequencing. For the phylogenetic analysis, all *bla* ~MIR~ gene sequences were collected from the NCBI nucleotide database using *bla* ~MIR~ as the key search term. A phylogenetic tree of the MIR amino acid sequences from both the database and this work was reconstructed by the maximum likelihood method, and the resulting trees were analyzed with bootstrap values of 100 replicates using MEGA 6.0 (<https://www.megasoftware.net/>).

2.4. Antimicrobial Susceptibility Testing {#sec2.4}
-----------------------------------------

Antimicrobial susceptibility testing was conducted for all tested antibiotics by the agar dilution method, and the minimum inhibitory concentrations (MICs) were interpreted based on the Clinical and Laboratory Standards Institute (CLSI) breakpoint criteria (CLSI, 2018) (<https://clsi.org/standards/products/packages/m02-m07-m100-package/>). Strain ATCC 25922 was used as the quality control strain. The 14 antibiotics (or antibiotics combination) used in this work were cephamycins (cefoxitin and cefminox), semisynthetic broad-spectrum penicillins (ampicillin and piperacillin), a first-generation cephalosporin (cefazolin), third-generation cephalosporins (ceftazidime, cefoperazone, cefotaxime, and ceftriaxone), a fourth-generation cephalosporin (cefoselis), a monobactam (aztreonam), an aminoglycoside (kanamycin), and combinations of antibiotics with *β*-lactamase inhibitors (piperacillin/tazobactam and imipenem/cilastatin sodium hydrate) ([Table 3](#tab3){ref-type="table"}).

2.5. Whole Genome Sequencing (WGS) of Y546 and Comparative Genomics Analysis {#sec2.5}
----------------------------------------------------------------------------

The *E. cloacae* Y546 genomic DNA was extracted with the AxyPrep Bacterial Genomic DNA Miniprep Kit (Axygen Scientific, Union City, CA, USA) and sequenced with Illumina HiSeq 2500 and Pacific Biosciences sequencers at Annoroad Gene Technology Co. Ltd. (Beijing, China). Reads derived from HiSeq 2500 sequencing were initially assembled de novo with SOAPdenovo software to obtain genome sequence contigs. Reads of approximately 10-20 kb in length from the Pacific Biosciences sequencing were mapped onto the primary assembly for contig scaffolding. Gaps were filled either by remapping the short reads from the HiSeq 2500 sequencing or by sequencing the gap PCR product. Potential ORFs were predicted and annotated using Glimmer3 (<http://www.cbcb.umd.edu/software/glimmer>) and BASys \[[@B19]\], respectively. GC view software was used to construct the basic genomic features. Annotations were revised using UniProt (<http://www.uniprot.org/>) and BLAST (<https://blast.ncbi.nlm.nih.gov/blast.cgi>). Plasmid replicons and plasmid incompatibility groups were predicted using Plasmid Finder (<https://cge.cbs.dtu.dk//services/PlasmidFinder/>). Furthermore, the multilocus sequence typing (MLST) database for *E. cloacae* (<https://pubmLst.org/ecloacae/>) was used to determine the sequence type of *E. cloacae* Y546.

The plasmid and chromosomal genomic sequences used in this study for the whole genome comparative analysis were downloaded from the NCBI database (<http://www.ncbi.nlm.nih.gov>). The plasmid and chromosome sequences were selected based on the comparison of the whole genome sequence (pY546) against the sequences of plasmids and chromosomes available in the NCBI database; a cutoff value (max score) of approximately 8700 was defined. For the comparative analysis of the heavy metal gene cluster regions on the pY546 plasmid, the sequences containing corresponding gene clusters with sequence identities of ≥80% with respect to those encoded on pY546 were obtained from the NCBI nucleotide database by BLASTn algorithms. Multiple sequence alignments were performed using MAFFT \[[@B20]\]. Comparisons of the nucleotide sequences were made using BLASTn. Insertion sequences were predicted using ISfinder \[[@B21]\]. Orthologous groups of genes from plasmids or chromosomes were identified using BLASTp and Inparanoid \[[@B22]\]. Additional bioinformatics software was written using Python (<https://www.python.org/>) and Biopython \[[@B23]\].

2.6. Pulsed-Field Gel Electrophoresis (PFGE) {#sec2.6}
--------------------------------------------

The clonal relatedness of MIR-producing *E. cloacae* isolates was assessed by *Xba*I (Takara Bio Inc., China) PFGE. Briefly, genomic DNA fragments were resolved on a 1% agarose (SeaKem Gold Agarose, Lonza) gel at 14°C, and electrophoresis was conducted at 6 V/cm using a CHEF PFGE instrument (Bio-Rad, USA) at a pulse time gradient of 2.25-55.5 s and a total run time of 18 h. *Salmonella enterica* serovar H9812 was used as a control. Cluster analysis was performed using an unweighted pair-group method with arithmetic (UPGMA) means. Isolates were allocated into genetic similarity clusters using a similarity cutoff value of 80% \[[@B24]\].

2.7. Nucleotide Sequence Accession Numbers {#sec2.7}
------------------------------------------

The sequences of the chromosome and the plasmid of Y546 and the *bla* ~MIR~ genes in this work have been submitted to NCBI GenBank with accession numbers of CP032916 (Y546), CP032915 (pY546), MK033024 (*bla* ~MIR-CG34~), MK033023 (*bla* ~MIR-Y490~), MK033025 (*bla* ~MIR-CG76~), MK033026 (*bla* ~MIR-Y546~), MK033021 (*bla* ~MIR-CG85~), and MK033022 (*bla* ~MIR-Y482~), respectively.

3. Results {#sec3}
==========

3.1. Mapping and Screening Results for the *β*-Lactamase Genes in the Sequenced Bacteria {#sec3.1}
----------------------------------------------------------------------------------------

A total of 75 *β*-lactamase gene sequences were collected from the database (Supplementary [Table S1](#supplementary-material-1){ref-type="supplementary-material"}). The pooled genomic DNA sequences of the 212 isolated strains generated approximately 34.1 gigabases. All reads ranged from 100 to 110 nucleotides in length. The mapping of the sequencing reads onto the reference sequences yielded the identification of resistance genes; in addition, the quantity of mapped reads on a specific reference could suggest the relative abundance of the reads in the sequenced samples. This analysis showed that the samples contained a total of 12 hits related to *β*-lactamase resistance genes. The most abundant gene was *bla* ~TEM~, which had a sequence depth of 466.15 (Supplementary [Table S2](#supplementary-material-1){ref-type="supplementary-material"}). The other genotypes with a greater abundance were *bla* ~SHV~, *bla* ~DHA~, and *bla* ~CTX-M~ (especially the *bla* ~CTX-M-9~ and *bla* ~CTX-M-1~ subtypes), while the genotypes with a lower abundance were *bla* ~Z~, *bla* ~VEB~, *bla* ~KLUC~, *bla* ~MIR~, *bla* ~SFO~ *, bla* ~AZECL~, *bla* ~OXA~, and *bla* ~ACT~. The screening results for the *bla* ~VEB~, *bla* ~Z~, *bla* ~AZECL~, and *bla* ~MIR~ genotypes revealed that among the 212 strains, only 0.47% (1/212; Y412), 0.94% (2/212; CG3 and CG4), 0.94% (2/212; Y411 and CG90), and 2.83% (6/212; CG34, Y490, CG76, Y546, CG85, and Y482) carried *bla* ~VEB~, *bla* ~Z~, *bla* ~AZECL~, and *bla* ~MIR~, respectively.

3.2. Cloning and Functional Detection of the Resistance Genes {#sec3.2}
-------------------------------------------------------------

Fourteen antimicrobial agents were used to detect the MIC levels of the *bla* ~MIR~ *-*positive wild-type strains and the recombinant strains expressing the cloned *bla* ~MIR~ genes (pET28a-*bla* ~MIR~/BL21). The MICs of the 14 antimicrobial agents against these strains are shown in [Table 3](#tab3){ref-type="table"}. The MICs for all 6 *bla* ~MIR~-positive wild-type strains (CG34, Y490, CG76, Y546, CG85, and Y482) demonstrated that they were resistant to 4 commonly used broad-spectrum beta-lactam antibiotics, including ampicillin, a first-generation cephalosporin (cefazolin), and cephamycins (cefmenoxime and cefoxitin), and *E. cloacae* CG76 displayed higher resistance levels than the other strains to all antibiotics tested. Like the host wild-type strains, the 6 recombinant strains expressing the cloned *bla* ~MIR~ genes (pET28a-*bla* ~MIR~/BL21) were resistant to ampicillin, cefazolin, cefmenoxime, and cefoxitin. In addition, the recombinants with two other extended-spectrum *β*-lactamase (ESBL) genes, namely, *bla* ~SHV-12~ and *bla* ~CTX-M-9a~, encoded on the Y546 chromosome displayed higher hydrolytic activity against these four *β*-lactam antibiotics.

3.3. Clonal Relatedness of the *bla* ~MIR~-Positive Strains and Genotypes and the Phylogenetic Tree Analysis of the *bla* ~MIR~ Genes {#sec3.3}
-------------------------------------------------------------------------------------------------------------------------------------

All 6 *bla* ~MIR~-positive strains (Y490, Y482 CG34, CG76, CG85, and Y546) had distinct *Xba*I PFGE patterns ([Figure 1](#fig1){ref-type="fig"}), indicating that the prevalence of *bla* ~MIR~-positive isolates was caused by disseminated gene transfer. Sequencing results showed that the *bla* ~MIR~ ORFs from strains CG85 and Y482 belonged to the *bla* ~MIR-17~ genotype, while the ORFs from strains CG34, CG76, Y490, and Y546 matched *bla* ~MIR-5~, *bla* ~MIR-21~, *bla* ~MIR-3~, and *bla* ~MIR-20~, respectively. These ORFs had 99% amino acid similarity to their respective reference sequences. To further analyze the evolutionary relationship of the 6 *bla* ~MIR~ genes identified in this work with other *bla* ~MIR~ genes, we performed a multiple sequence alignment on a total of 30 *bla* ~MIR~ variants including the 6 *bla* ~MIR~ genes identified in this study. The multiple-sequence alignment identified the Pro380Leu variant in *bla* ~MIR-Y546~, *bla* ~MIR-Y482~, and *bla* ~MIR-Y490~ and the Ala381Gln variant in *bla* ~MIR-CG76~, *bla* ~MIR-CG85~, *bla* ~MIR-Y546~, *bla* ~MIR-Y482~, and *bla* ~MIR-Y490~. The Asn206His variant was identified only in *bla* ~MIR-CG34~ ([Figure 2](#fig2){ref-type="fig"}). The phylogenetic analysis ([Figure 3](#fig3){ref-type="fig"}) showed that with the exception of 2 sequences from CG85 and Y482 that had the same amino acid sequence and were located in the same branch, the 6 MIR proteins were located in unique branches.

3.4. General Features of the Y546 Genome {#sec3.4}
----------------------------------------

The genome of *E. cloacae* strain Y546 consists of a chromosome and a plasmid (pY546); the general features of the Y546 genome are shown in [Table 4](#tab4){ref-type="table"}. The chromosome is 4.78 Mb in length, harbors 4312 ORFs, and has an average GC content of 56.02%. In addition to an *ampC* gene *bla* ~MIR~, the chromosome also encodes two other extended-spectrum *β*-lactamase (ESBL) genes, namely, *bla* ~CTX-M-9~ and *bla* ~SHV-12~. MLST determined that *E. cloacae* strain Y546 contains the *leuS*-90, *rpoB*-20, *gyrB*-127, *dnaA*-120, *fusA*-25, and *rplB*-12 alleles and belongs to the sequence type ST466. The pY546 plasmid, an IncHI1B plasmid, is 208,740 bp in length and encodes 232 ORFs (Supplementary [Table S3](#supplementary-material-1){ref-type="supplementary-material"}), of which 56.89% (132/232) encode proteins with known functions, and it contains a number of accessory modules identified at different sites within the backbone. pY546 contained an incomplete copper resistance operon (*pcoBCDE/cusRS*, ORF91-96) and several clusters of genes related to resistance to other metals, including arsenic (*arsABCDR*, ORF100-105), tetrathionate (*ttrABCDRS*, ORF142-146) and tellurite (*terCDEF*, ORF153-156). This plasmid also encodes numerous metallic ion metabolism and transfer proteins, such as a potassium transporter (*Kef*, ORF109), a fluoride ion transporter (*CrcB*, ORF113), divalent cation transporters (ORF111 and ORF112), and voltage-gated chloride channel proteins (ORF120 and ORF121). In addition, TonB-dependent receptors (TBDRs, ORF12-14), which are involved in the uptake of essential nutrients, are identified in pY546.

3.5. Comparative Genomic Analysis of the pY546 Plasmid Genome {#sec3.5}
-------------------------------------------------------------

A total of six sequences having greater than 40% nucleotide sequence identity to the pY546 sequence were retrieved from GenBank. Four of these were plasmid sequences, namely, pKPN-332 of *K. pneumoniae* strain KPNIH39 (49%, CP014763.1), pKPN-3967 of *K. pneumoniae* strain KPNIH49 (47%, CP026186.1), plasmid unnamed 1 of *K. pneumoniae* strain KSB2_1B (44%, CP024507.1), and pKPN-262 of *K. pneumoniae* subsp. pneumoniae KPNIH27 (44%, CP007734.1). The other two were chromosome sequences of *E. coli* S43 (41%, CP010237.1) and *E. coli* MEM (40%, CP012378.1) ([Figure 4](#fig4){ref-type="fig"}). Comparative genomics analysis showed that pY546 is approximately 80-100 kb smaller than any of the three named plasmids (pKPN-332, pKPN-3967, and pKPN-262). The sequences of 102 genes (43.4%, 102/235) on pY546 showed high similarity (\>90%) with those on each of the three named plasmids. These plasmids shared a conserved backbone sequence with pY546; the backbone included the replication initiation gene (*rep*A), stable maintenance genes (*par*AB or *sop*AB), DNA mismatch repair system genes (*mutS*), and so on. On the other hand, all these plasmids possessed their own variable regions, which mainly included heavy metal (*cop*, *ars*, and *ter*) resistance gene clusters and hypothetical genes. The tetrathionate resistance genes (*ttrABCRS*) encoded on pY546 were not present in the three named plasmids. The named plasmids also had multiple copies of common mobile elements, such as transposons and insertion elements (IS). In the two *E. coli* (S43 and MEM) chromosome sequences, the *pco* gene cluster (*pcoABCDRSE*) was detected in MEM but not in S43. Nevertheless, *arsBCD*, which is a part of the arsenic resistance determinants, was present in both S43 and MEM. The tetrathionate resistance genes were unique to pY546, while the chromosome of S43 carried the *ter* operon, but the MEM chromosome did not ([Figure 4](#fig4){ref-type="fig"}). The *ter* operon *terCDEF* was detected and in the same orientation in the three plasmids pKPN-332, pKPN-3967, and pKPN-262.

3.6. Comparative Analysis of Copper and Arsenic Resistance Gene Regions on the pY546 Plasmid {#sec3.6}
--------------------------------------------------------------------------------------------

Comparative analysis of an 8.7 kb fragment of pY546 encoding both copper (*pco*) and arsenic (*ars*) operons showed that the 5 sequence fragments with the highest similarity to that of pY546 were 4 fragments from the pKO_JKo3_1 plasmid of *Klebsiella oxytoca* JKo3 (100%, AP014952.1), the pKPN1705-1 plasmid of *Klebsiella quasivariicola* KPN1705 (100%, CP022824.1), the CSK29544_3p plasmid of *Cronobacter sakazakii* ATCC 29544 (100%, CP011050.1), and the pKPN-262 plasmid of *Klebsiella pneumoniae* subsp. *pneumoniae* KPNIH27 (82%, CP007734.1) and 1 fragment from the chromosome of *Escherichia coli* MEM (CP012378.1, 82%) ([Figure 5](#fig5){ref-type="fig"}). The fragment sharing the highest sequence identity with that of pY546 (from *E. cloacae*) was in the CSK29544_3p plasmid of *Enterobacter sakazakii.* All sequences except for pY546 contained the complete copper (*pco*) operon structure. pY546, however, contained an incomplete copper (*pco*) operon with a truncated *pcoB* (△*pcopB*) gene and without *pcoA* gene. Four (pY546, CSK29544_3p, pKO_Jko3_1, and pKPN1705-1) sequences contained the complete *ars* operon gene clusters. Moreover, the latter two plasmids (pKO_Jko3_1 and pKPN1705-1) contained an additional functional gene, namely, *arsH*, which encoded an organoarsenical oxidase (NADPH-dependent FMN reductase) \[[@B25]\] and conferred resistance to trivalent forms of organoarsenic compounds. Two of the plasmids (pKO_Jko3_1 and pKPN1705-1) were also identified to contain two copies of *arsA and arsD* with inverted orientations. The CSK29544_3p plasmid contained the same gene arrangement and content as pY546, but pY546 and CSK29544_3p contained fewer genes than the other two plasmids (pKO_Jko3_1 and pKPN1705-1). The pY546 and CSK29544_3p plasmids lacked *arsH* and contained only one copy each of *arsAD*, which was oriented oppositely in these two plasmids. On the other hand, the *arsBCRH* gene cluster was identified in pKPN-262, while the MEM chromosome contained *arsBCR* but lacked *arsH*.

4. Discussion {#sec4}
=============

The production of *β*-lactamases is the predominant *β*-lactam resistance mechanism in gram-negative bacteria. The Ambler molecular classification categorizes these *β*-lactamases into four enzyme classes, namely, A, B, C, and D. Class A, C, and D enzymes all possess an active site serine, whereas class B *β*-lactamases are metalloenzymes with a Zn^2+^ ion(s) in the active site \[[@B26]\]. In this study, a total of 12 *β*-lactamase-encoding genes, including 7 class A *β*-lactamase genes (*bla* ~SHV~, *bla* ~CTX-M~, *bla* ~Z~, *bla* ~VEB~, *bla* ~KLUC~, *bla* ~SFO~, and *bla* ~TEM~), 4 class C *β*-lactamase genes (*bla* ~MIR~, *bla* ~DHA~, *bla* ~ACT~, and *bla* ~AZECL-29~), and 1 class D *β*-lactamase gene (*bla* ~OXA~) were identified in 212 *E. cloacae* isolates from a teaching hospital in South China. Over the past years, a variety of metalloenzymes (NDM- and IMP-type) have been found in *E. cloacae* and have contributed to infectious outbreaks in China \[[@B27]\] and Japan \[[@B28]\]. However, we did not detect any genes encoding class B metalloenzymes in these 212 *E. cloacae* isolates.

The class A enzymes are regarded as extended-spectrum *β*-lactamases (ESBLs) that can hydrolyze extended-spectrum cephalosporins; they are inhibited by clavulanic acid and are spreading widely among *Enterobacteriaceae*. The CTX-M enzymes are replacing the SHV and TEM enzymes as the most prevalent type of ESBL in *Enterobacteriaceae* \[[@B29], [@B30]\]. Additional clinically relevant types of ESBLs include the VEB, PER, GES, TLA, IBC, SFO-1, BES-1, and BEL-1 types. The SFO-1 *β*-lactamase was first reported in 1988 in a clinical *E. cloacae* isolate in Japan, and it confers resistance to third-generation cephalosporins (Matsumoto & Inoue, 1999); VEB was reported in China during an outbreak of infection caused by *E. cloacae* \[[@B31]\]. No document has yet reported the identification of the *bla* ~Z~ gene that encodes class A enzymes in *E. cloacae*, and the *bla* ~Z~ gene has been found only once in *Staphylococcus aureus* \[[@B16]\]. In this work, however, we isolated two *E. cloacae* strains (CG3 and CG4) that carried the *bla* ~Z~ gene.

In addition to the *bla* ~MIR~ and *bl*a~DHA~ genes identified in this work, genes encoding AmpC enzymes belonging to Ambler class C and Bush-Jacoby group 1 include *bla* ~CMY~, *bla* ~FOX~, *bla* ~LAT~, *bla* ~ACT~, *bla* ~MOX~, *bla* ~ACC~, and *bla* ~BIL~ and their derivatives (H. \[[@B32]\]). The emergence of AmpC-producing *Enterobacter* spp. has been observed globally in health care-associated settings and in the community \[[@B33]\]. However, unlike most of the AmpC genes, *bla* ~MIR~ has been found only in some strains of several *Enterobacter* spp., mainly in strains of *E. cloacae*. A total of 24 *bla* ~MIR~ nucleotide sequences (between the *bla* ~MIR-1~ and *bla* ~MIR-21~ subtypes) are available in the NCBI nucleotide database; these sequences mainly came from the *ECC*, such as *E. cloacae* and *E. aerogenes*, as well as strains of *K. pneumoniae* and *E. coli*. In this work, 6 MIRs belonged 5 subtypes, including *bla* ~MIR-3~, *bla* ~MIR-5~, *bla* ~MIR-17~, *bla* ~MIR-21~, and *bla* ~MIR-20~. Although the *bla* ~MIR~ gene has been primarily identified on bacterial chromosomes, it is also encoded on plasmids. The AmpC *β*-lactamase *bla* ~MIR-1~ was first described in *K. pneumoniae* plasmids \[[@B34]\]; *bla* ~MIR-1~ confers resistance to penicillins and broad-spectrum cephalosporins, including cefoxitin and ceftibuten, but not to cefepime, cefpirome, meropenem, or imipenem. The resistance features of *bla* ~MIR~ genes in human and animal isolates were different from those of some plasmid-encoded AmpC-type *β*-lactamase genes, such as *bla* ~DHA~ and *bla* ~CMY~, and have been reported worldwide to hydrolyze third-generation cephalosporins \[[@B35], [@B36]\]. The *bla* ~MIR~ gene identified in this work was encoded on the chromosome and showed high sequence identity with other homologous *bla* ~MIR~ genes found in other *Enterobacteriaceae*. Like the other previously reported MIRs, they showed resistance to ampicillin, cefazolin, cefmenoxime, and cefoxitin, but sensitive to fourth-generation cephalosporins (cefoselis) and monobactam (aztreonam).

To adapt to environmental changes, bacteria often harbor genes conferring resistance to toxic metal compounds; these genes include those encoding copper and arsenic ion transportation systems \[[@B37]\]. Copper sulfate is a common feed supplement for pigs, chickens, and calves worldwide. The copper-binding operon system (*PcoBCDE* and *CusR/S*), which is known to transport copper-derived compounds out of the bacterial cell to balance the concentration of copper salts, was elaborated on the pRJ1004 plasmid of *E. coli* isolates from piggeries in which the animals were provided food supplemented with copper sulfate \[[@B38]\]. Despite the identity of arsenic and arsenite compounds as high-toxicity compounds that are neither used in agriculture nor found in either the community or the hospital sector, the presence of arsenic resistance determinants on *Enterobacteriaceae* plasmids, especially the IncH-type plasmids, has been described before \[[@B9]\]. Three prototypes of *ars* operons, including the three-, four-, and five-gene arsenic resistance determinants, namely, *arsABC*, *arsABCD*, and *arsABCDR*, respectively, have been well documented, although novel resistance mechanisms have also been described \[[@B39]\]. The *arsABCDR* operon is related to resistance to arsenic-derived compounds, including arsine, arsenic, arsenite, and arsenate. Heavy metal resistance genes or gene clusters have been widely identified in different genera of both gram-positive and gram-negative bacteria and are encoded on both chromosomes and plasmids. In this work, on the plasmid pY546, we found four clusters of genes conferring resistance to heavy metals, such as arsenic (*arsABCDR*), tetrathionate (*ttrABCDRS*), and tellurite (*terCDEF*) as well as an incomplete copper resistance operon (*pcoBCDE/cusRS*). We must expect that bacteria have adapted to heavy metals with an increasing frequency.

5. Conclusion {#sec5}
=============

In this work, through high-throughput sequencing, we identified twelve *β*-lactamase genotypes in 212 clinical *E. cloacae* isolates; of these, *bla* ~Z~ has not yet been reported in *E. cloacae*. Furthermore, whole genome analysis of the *bla* ~MIR~-carrying *E. cloacae* strain Y546 demonstrated that the strain harbored a large plasmid carrying a variety of gene clusters and genes, such as heavy metal resistance gene clusters (e.g., the *pco*, *ars*, *ter*, and *ttr* operons), conferring resistance to antimicrobials. Comparative genomics analysis showed that the sequences sharing the highest similarity to pY546 were plasmids from *K. pneumoniae* strains (44-49% similarity) and the chromosome of *E. coli* (40-41% similarity) and that the sequence fragments with the highest similarity to heavy metal resistance gene clusters on pY546 were from other plasmids and other chromosome sequences. The colocalization of antibiotic resistance genes and heavy metal resistance genes in the genomes of clinical pathogens, which may facilitate the persistence, coselection, and dissemination of these genes between different bacterial species or genera, is alarming and needs further surveillance.

The work was funded by grants from the National Natural Science Foundation of China (31500109, 81501808, and 80215049) and the Science and Technology Foundation of Wenzhou City (Y20170205).

Data Availability
=================

The data used to support the findings of this study are included within the article.

Additional Points
=================

*Highlights*. Twelve *β*-lactamase genotypes, including *bla* ~SHV~, *bla* ~TEM~, *bla* ~DHA~, *bla* ~CTX-M~, *bla* ~Z~, *bla* ~VEB~, *bla* ~KLUC~, *bla* ~MIR~, *bla* ~SFO~, *bla* ~AZECL-29~, *bla* ~OXA~, and *bla* ~ACT~, were identified in 212 *E. cloacae* genomes. *bla* ~Z~ was found in *E. cloacae* for the first time. *bla* ~MIR~ was identified in six *E. cloacae* strains that were not clonally related. The gene clusters related to resistance to heavy metals (such as copper, arsenic, and tellurite) were identified to be encoded on the pY546 plasmid. The sequences with the highest similarity to pY546 were on plasmids from *K. pneumoniae* strains and on *E. coli* chromosomes; in addition, the sequence fragments with the highest similarity to the heavy metal resistance gene clusters on pY546 were from other sources.
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Table S1: the reference *β*-lactamase gene sequences collected from GenBank. Table S2: the mapping result of *β*-lactamase resistance genes in the *E. cloacae* pooled genomic sequences. Table S3: annotation result of the pY546 genome.

###### 

Click here for additional data file.

![Pulsed-field gel electrophoresis (PFGE) analysis of the 6 *bla* ~MIR~-positive *E. cloacae* isolates. PFGE result showed that all 6 *bla* ~MIR~-positive isolates had a totally distinct PFGE pattern.](IJG2018-4989602.001){#fig1}

![Comparison of the MIR amino acid sequences from 6 *E. cloacae* isolates.](IJG2018-4989602.002){#fig2}

![Phylogenetic tree of 30 MIR amino acid sequences. The "●" symbols indicate the MIRs of this study.](IJG2018-4989602.003){#fig3}

![Complete sequence of the pY546 plasmid and comparative genomic analysis of the pY546 plasmid sequence with other sequences. The circles (from innermost to outermost) represent (i) the scale in kb; (ii) the cumulative GC skew; (iii) the GC content; (iv) the annotated coding sequences with selected genes indicated according to the gene function: heavy metal resistance genes in red arrows, transposase genes, IS elements in bottle-green arrows, and hypothetical proteins in dark gray arrows; (v) circles (from inside to outside) representing three homologous plasmids (pKPN-332, CP014763.1; pKPN-3967, CP026186.1; and pKPN-262, CP007734.1) and two chromosome fragments (S43, CP010237.1, and MEM, CP012378.1), respectively.](IJG2018-4989602.004){#fig4}

![Comparative analysis of the copper and arsenic resistance gene clusters of pY546 and other sequences from different bacteria. The homologous gene clusters among plasmids pY546, CSK29544_3P (CP011050.1), pKO_JKo3_1 (AP014952.1), pKPN1705-1 (CP022824.1), pKPN-262 (CP007734.1), and MEM (CP012378.1) with the copper resistance gene clusters in bottle green, and the arsenic resistance gene cluster in orange. Annotated coding sequences are displayed as arrows. Coding sequences are colored based on their assigned gene functions.](IJG2018-4989602.005){#fig5}

###### 

Bacteria and plasmids used in this study.

  Strain                              Relevant characteristic(s)                                          Reference or source
  ----------------------------------- ------------------------------------------------------------------- ---------------------
  BL21                                *E. coli* BL21 was used as a host for the cloned *bla* ~MIR~ gene   \[[@B14]\]
  ATCC25922                           *E. coli* ATCC25922 is FDA clinical isolate                         \[[@B14]\]
  CG34                                *bla* ~MIR~-producing isolate of *E. cloacae* CG34                  This study
  CG76                                *bla* ~MIR~-producing isolate of *E. cloacae* CG76                  This study
  CG85                                *bla* ~MIR~-producing isolate of *E. cloacae* CG85                  This study
  Y546                                *bla* ~MIR~-producing isolate of *E. cloacae* Y546                  This study
  Y482                                *bla* ~MIR~-producing isolate of *E. cloacae* Y482                  This study
  Y490                                *bla* ~MIR~-producing isolate of *E. cloacae* Y490                  This study
  pET28a/BL21                         BL21 carrying expression vector pET28a, km^r^                       This study
  pET28a-*bla* ~MIR-CG34~/BL21        BL21 carrying recombinant plasmid pET28a-*bla* ~MIR-CG34~           This study
  pET28a-*bla* ~MIR-Y490~/BL21        BL21 carrying recombinant plasmid pET28a-*bla* ~MIR-Y490~           This study
  pET28a-*bla* ~MIR-CG76~/BL21        BL21 carrying recombinant plasmid pET28a*-bla* ~MIR-CG76~           This study
  pET28a-*bla* ~MIR-Y546~/BL21        BL21 carrying recombinant plasmid pET28a-*bla* ~MIR-Y546~           This study
  pET28a-*bla* ~MIR-CG85~/BL21        BL21 carrying recombinant plasmid pET28a-*bla* ~MIR-CG85~           This study
  pET28a-*bla* ~MIR-Y482~/BL21        BL21 carrying recombinant plasmid pET28a-*bla* ~MIR-Y482~           This study
  pET28a-*bla* ~CTX-M-9a-Y546~/BL21   BL21 carrying recombinant plasmid pET28a-*bla* ~CTX-M-9a-Y546~      This study
  pET28a-*bla* ~SHV-12-Y546~/BL21     BL21 carrying recombinant plasmid pET28a-bla~SHV-12-Y546~           This study

km: kanamycin; ^r^: resistant.

###### 

Primers used in the study for the detection of *β*-lactamase-encoding genes.

  Primer        Target(s)                                     Sequence (5′-3′)                             Annealing temperature (°C)   Amplicon size (bp)   Reference
  ------------- --------------------------------------------- -------------------------------------------- ---------------------------- -------------------- ------------
  veb-sf        *bla* ~VEB~                                   GATTGCTTTAGCCGTTTTGTC                        50                           452                  \[[@B15]\]
  veb-sr        ATCGGTTACTTCCTGTTGTTGTTTC                                                                                                                    
  z-sf          *bla* ~Z~                                     ACAGTTCACATGCCAAAGAGT                        50                           479                  \[[@B16]\]
  z-sr          CTTACCGAAAGCAGCAGGTG                                                                                                                         
  mir-sf        *bla* ~MIR~                                   GCCGCACCGATGTCCGAAAAA                        50                           545                  \[[@B18]\]
  mir-sr        GGTTTAAAGACCCGCGTCGTCATGG                                                                                                                    
  azecl-29-sf   *bla* ~AZECL-29~                              GTCTTTACGCTAACACCAGCATCGG                    50                           381                  \[[@B17]\]
  azecl-29-sr   TCAGCATTTCCCAGCCCAATC                                                                                                                        
  veb-ff        *bla* ~VEB~                                   [*CGGGATCC*]{.ul}ATGAAAATCGTAAAAAGGATATTAT   50                           918                  This study
  veb-fr        [*CCCAAGCT*]{.ul}TTATTTATTCAAATAGTAATTCCACG                                                                                                  
  z-ff          *bla* ~Z~                                     [*CGGGATCC*]{.ul}ATGAAAAAGTTAATATTTTTAATTG   50                           864                  This study
  z-fr          [*CCCAAGCT*]{.ul}TTAAAATTCCTTCATTACACTCTTG                                                                                                   
  mir-ff        *bla* ~MIR~                                   [*CGGGATCC*]{.ul}ATGATGACAAAATCCCTAAGCTGTG   66                           1164                 This study
  mir-fr        [*CCCAAGCT*]{.ul}TTACTGCAGCGCGTCGAGGATACGG                                                                                                   
  azecl-29-ff   *bla* ~AZECL-29~                              [*CGGAATTC*]{.ul}ATGATGAAAAAAAACCTAAGCTGTG   60                           1164                 This study
  azecl-29-fr   [*CCCAAGCT*]{.ul}TTACTGCAGCGCGTCGAGGATACG                                                                                                    
  ctx-m-9a-ff   *bla* ~CTX-M-9a~                              [*CGGGATCC*]{.ul}ATGGTGACAAAGAGAGTGCAACGGA   60                           876                  This study
  ctx-m-9a-fr   [*CCAAGCTT*]{.ul}TTACAGCCCTTCGGCGATGATTCTC                                                                                                   
  shv-12-ff     *bla* ~SHV-12~                                [*CGGGATCC*]{.ul}GTGGTTATGCGTTATATTCGCCTGT   60                           867                  This study
  shv-12-fr     [*CCAAGCTT*]{.ul}TTAGCGTTGCCAGTGCTCGATCAGC                                                                                                   

Underlined sequences denote restriction endonuclease sites. sf: forward screening primer; sr: reverse screening primer; ff: forward full-length primer; fr: reverse full-length primer.

###### 

The MIC values of antibacterial drugs for the strains (*μ*g/mL).

  Strains                              AMP      KAN   CAZ      CTX      CPZ      CMN      CEF      CFZ      FOX      CRO      ATM      PRL   PTZ   IMC
  ------------------------------------ -------- ----- -------- -------- -------- -------- -------- -------- -------- -------- -------- ----- ----- ------
  ATCC25922                            4        2     0.25     0.0625   0.125    1        0.125    2        4        0.0313   0.125    2     4     0.25
  BL21                                 0.5      4     0.0625   0.0156   0.0156   1        0.0313   2        2        0.0156   0.0156   0.5   0.5   0.5
  pET-28a/BL21^∗^                      0.5      32    0.0625   0.0156   0.0156   1        0.0313   2        2        0.0156   0.0156   0.5   0.5   0.5
  CG34                                 256      0.5   0.125    0.125    0.0625   1024     0.0625   512      1024     0.0313   0.25     2     2     4
  Y490                                 256      2     0.5      0.25     1        \>1024   0.125    512      1024     0.5      0.0313   2     4     2
  CG76                                 \>1024   8     128      128      64       1024     16       \>1024   1024     512      32       512   32    8
  Y546                                 512      2     2        1        2        \>1024   0.25     1024     1024     2        1        8     8     4
  CG85                                 \>1024   4     1        1        1        \>1204   0.25     1024     \>1024   1        0.25     4     4     4
  Y482                                 64       2     0.25     0.125    0.25     1024     256      512      0.0625   0        0.125    2     2     0.5
  pET-28a-*bla* ~MIR~ (CG34)/BL21^∗^   128      64    4        4        1        32       0.125    256      32       4        1        8     8     1
  pET-28a-*bla* ~MIR~ (Y490)/BL21^∗^   128      64    4        4        0.5      32       0.0625   256      32       4        1        8     4     1
  pET-28a-*bla* ~MIR~ (CG76)/BL21^∗^   128      64    4        4        1        32       0.0313   256      32       4        1        8     4     1
  pET-28a-*bla* ~MIR~ (Y546)/BL21^∗^   128      64    4        4        1        32       0.0625   256      32       4        1        8     8     1
  pET-28a-*bla* ~MIR~ (CG85)/BL21^∗^   128      64    4        4        1        32       0.125    256      32       4        1        8     8     1
  pET-28a-*bla* ~MIR~ (Y482)/BL21^∗^   128      64    4        4        1        32       0.125    256      32       4        1        8     8     1
  pET-28a-*bla* ~CTX-M-9a~/BL21^∗^     8        64    0.25     4        1        4        0.03     64       4        0.03     0.03     2     1     1
  pET-28a-*bla* ~SHV-12~/BL21^∗^       8        64    2        4        1        4        0.25     64       4        0.03     0.03     32    2     2

^∗^IPTG was added to a final concentration of 1 mmol/L to standard Mueller-Hinton (M-H) agar plates. All MIC determinations were performed by agar dilution assays. FOX: cefoxitin; CAZ: ceftazidime; CTX: cefotaxime; AMP: ampicillin; KAN: kanamycin; CPZ: cefoperazone; CMN: cefminox; CEF: cefoselis; CFZ: cefazolin; CRO: ceftriaxone; ATM: aztreonam; PRL: piperacillin; PTZ: piperacillin/tazobactam; IMC: imipenem/cilastatin sodium hydrate.

###### 

General features of the Y546 genome.

                                Chromosome          Plasmid
  ----------------------------- ------------------- -------------
  Size (bp)                     4,787,919           208,741
  GC content (%)                56.02               52.63
  ORFs                          4312                234
  Known proteins                3476 (80.6%)        137 (58.5%)
  Hypothetical proteins         836 (19.4%)         97 (41.5%)
  Protein coding (%)            88.02               82.80
  Average ORF length (bp)       977                 738
  Average protein length (aa)   324                 245
  tRNAs                         85                  0
  rRNA operons                  (16S-23S-5S) ^∗^7   0
  16S-23S-5S-5S                                     
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